Wesley T O'Neal1, Jimmy T Efird2, Joseph Yeboah2, Saman Nazarian2, Alvaro Alonso2, Susan R Heckbert2, Elsayed Z Soliman2. 1. From the Department of Internal Medicine (W.T.O.), Department of Internal Medicine, Section on Cardiology (J.Y., E.Z.S.), and Department of Epidemiology and Prevention, Epidemiological Cardiology Research Center (EPICARE) (E.Z.S.), Wake Forest School of Medicine, Winston-Salem, NC; Department of Cardiovascular Sciences, East Carolina Heart Institute, Brody School of Medicine, East Carolina University, Greenville, NC (J.T.E.); Departments of Medicine and Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD (S.N.); Department of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis (A.A.); and Cardiovascular Health Research Unit, Department of Epidemiology, University of Washington, Group Health Research Institute, Seattle (S.R.H.). woneal@wakehealth.edu. 2. From the Department of Internal Medicine (W.T.O.), Department of Internal Medicine, Section on Cardiology (J.Y., E.Z.S.), and Department of Epidemiology and Prevention, Epidemiological Cardiology Research Center (EPICARE) (E.Z.S.), Wake Forest School of Medicine, Winston-Salem, NC; Department of Cardiovascular Sciences, East Carolina Heart Institute, Brody School of Medicine, East Carolina University, Greenville, NC (J.T.E.); Departments of Medicine and Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD (S.N.); Department of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis (A.A.); and Cardiovascular Health Research Unit, Department of Epidemiology, University of Washington, Group Health Research Institute, Seattle (S.R.H.).
Abstract
OBJECTIVE: It is unknown whether endothelial dysfunction precedes atrial fibrillation (AF) development. The objective of this study was to examine the association of brachial flow-mediated dilation (FMD) with incident AF. APPROACH AND RESULTS: A total of 2936 participants (mean age, 61±9.9 years; 50% women; 66% nonwhites) from the Multi-Ethnic Study of Atherosclerosis with available ultrasound brachial FMD measurements who were free of baseline AF were included in this analysis. Baseline (2000-2002) FMD was computed from the percentage difference (%FMD) in brachial artery diameter and maximum diameter during measured vasodilator response. AF was ascertained from hospitalization data including Medicare claims during a median follow-up of 8.5 years. Probability-weighted Cox proportional-hazards regression was used to compute hazard ratios and 95% confidence intervals for the association between FMD as a continuous variable (%FMD values per 1-SD increase) and incident AF. Incident AF was detected in 137 (4.7%) participants. Those with %FMD values below the sex-specific median value (median %FMD; men, 3.6%; women, 4.2%; incidence rate per 1000 person-years, 7.3; 95% confidence interval, 5.9-9.0) were more likely to develop AF than people whose %FMD values were above the median value (incidence rate per 1000 person-years, 4.5; 95% confidence interval, 3.4-5.8; log-rank P=0.0043). In a multivariable Cox regression analysis, each 1-SD increase in %FMD values (SD, 2.8%) was associated with less incident AF (hazard ratio, 0.84; 95% confidence interval, 0.70-0.99). These results were consistent across subgroups stratified by age, sex, and race/ethnicity. CONCLUSIONS: Smaller brachial FMD values are associated with higher rates of AF, suggesting a role for endothelial dysfunction in AF pathogenesis.
OBJECTIVE: It is unknown whether endothelial dysfunction precedes atrial fibrillation (AF) development. The objective of this study was to examine the association of brachial flow-mediated dilation (FMD) with incident AF. APPROACH AND RESULTS: A total of 2936 participants (mean age, 61±9.9 years; 50% women; 66% nonwhites) from the Multi-Ethnic Study of Atherosclerosis with available ultrasound brachial FMD measurements who were free of baseline AF were included in this analysis. Baseline (2000-2002) FMD was computed from the percentage difference (%FMD) in brachial artery diameter and maximum diameter during measured vasodilator response. AF was ascertained from hospitalization data including Medicare claims during a median follow-up of 8.5 years. Probability-weighted Cox proportional-hazards regression was used to compute hazard ratios and 95% confidence intervals for the association between FMD as a continuous variable (%FMD values per 1-SD increase) and incident AF. Incident AF was detected in 137 (4.7%) participants. Those with %FMD values below the sex-specific median value (median %FMD; men, 3.6%; women, 4.2%; incidence rate per 1000 person-years, 7.3; 95% confidence interval, 5.9-9.0) were more likely to develop AF than people whose %FMD values were above the median value (incidence rate per 1000 person-years, 4.5; 95% confidence interval, 3.4-5.8; log-rank P=0.0043). In a multivariable Cox regression analysis, each 1-SD increase in %FMD values (SD, 2.8%) was associated with less incident AF (hazard ratio, 0.84; 95% confidence interval, 0.70-0.99). These results were consistent across subgroups stratified by age, sex, and race/ethnicity. CONCLUSIONS: Smaller brachial FMD values are associated with higher rates of AF, suggesting a role for endothelial dysfunction in AF pathogenesis.
Authors: Pasquale Perrone-Filardi; Alberto Cuocolo; Gregorio Brevetti; Antonio Silvestro; Giovanni Storto; Santo Dellegrottaglie; Luigi Corrado; Maria Cafiero; Roberta Camerino; Michele Polimeno; Annamaria Zarrilli; Gianluca Caiazzo; Antonio Maglione; Andrea Petretta; Massimo Chiariello Journal: Am J Cardiol Date: 2005-09-19 Impact factor: 2.778
Authors: T Neunteufl; R Katzenschlager; A Hassan; U Klaar; S Schwarzacher; D Glogar; P Bauer; F Weidinger Journal: Atherosclerosis Date: 1997-02-28 Impact factor: 5.162
Authors: Young M Kim; Tomasz J Guzik; Yin Hua Zhang; Mei Hua Zhang; Hassan Kattach; Chandi Ratnatunga; Ravi Pillai; Keith M Channon; Barbara Casadei Journal: Circ Res Date: 2005-08-25 Impact factor: 17.367
Authors: M Haïssaguerre; P Jaïs; D C Shah; A Takahashi; M Hocini; G Quiniou; S Garrigue; A Le Mouroux; P Le Métayer; J Clémenty Journal: N Engl J Med Date: 1998-09-03 Impact factor: 91.245
Authors: D S Celermajer; K E Sorensen; D J Spiegelhalter; D Georgakopoulos; J Robinson; J E Deanfield Journal: J Am Coll Cardiol Date: 1994-08 Impact factor: 24.094
Authors: D S Celermajer; K E Sorensen; V M Gooch; D J Spiegelhalter; O I Miller; I D Sullivan; J K Lloyd; J E Deanfield Journal: Lancet Date: 1992-11-07 Impact factor: 79.321
Authors: D S Celermajer; K E Sorensen; D Georgakopoulos; C Bull; O Thomas; J Robinson; J E Deanfield Journal: Circulation Date: 1993-11 Impact factor: 29.690
Authors: G E McVeigh; G M Brennan; G D Johnston; B J McDermott; L T McGrath; W R Henry; J W Andrews; J R Hayes Journal: Diabetologia Date: 1992-08 Impact factor: 10.122
Authors: Alvaro Alonso; Sunil K Agarwal; Elsayed Z Soliman; Marietta Ambrose; Alanna M Chamberlain; Ronald J Prineas; Aaron R Folsom Journal: Am Heart J Date: 2009-07 Impact factor: 4.749
Authors: Ronnier J Aviles; David O Martin; Carolyn Apperson-Hansen; Penny L Houghtaling; Pentti Rautaharju; Richard A Kronmal; Russell P Tracy; David R Van Wagoner; Bruce M Psaty; Michael S Lauer; Mina K Chung Journal: Circulation Date: 2003-11-17 Impact factor: 29.690
Authors: Parveen K Garg; Traci M Bartz; Gregory Burke; John S Gottdiener; David Herrington; Susan R Heckbert; Jorge R Kizer; Nona Sotoodehnia; Kenneth J Mukamal Journal: Vasc Health Risk Manag Date: 2021-03-11
Authors: Clara Marincowitz; Ingrid Webster; Corli Westcott; Nandu Goswami; Patrick de Boever; Gerald Seidel; Hans Strijdom Journal: Cardiovasc J Afr Date: 2020-11-13 Impact factor: 1.167